Browsing by Author Maur, Michela

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 1 to 3 of 3
TitleAuthor(s)Issue Date
 
A first-in-human phase 1/2 study of FGF401 and combination of FGF401 with spartalizumab in patients with hepatocellular carcinoma or biomarker-selected solid tumors
Journal:Journal of Experimental & Clinical Cancer Research
Chan, Stephen L.Schuler, MartinKang, Yoon KooYen, Chia JuiEdeline, JulienChoo, Su PinLin, Chia ChiOkusaka, TakujiWeiss, Karl HeinzMacarulla, TeresaCattan, StéphaneBlanc, Jean FredericLee, Kyung HunMaur, MichelaPant, ShubhamKudo, MasatoshiAssenat, EricZhu, Andrew X.Yau, ThomasLim, Ho YeongBruix, JordiGeier, AndreasGuillén-Ponce, CarmenFasolo, AngelicaFinn, Richard S.Fan, JiaVogel, ArndtQin, ShukuiRiester, MarkusKatsanou, VasilikiChaudhari, MonicaKakizume, TomoyukiGu, YiPorta, Diana GrausMyers, AndreaDelord, Jean Pierre
2-Jun-2022
 
A phase Ib/II trial of capmatinib plus spartalizumab vs. spartalizumab alone in patients with pretreated hepatocellular carcinoma
Journal:JHEP Reports
Santoro, ArmandoAssenat, EricYau, ThomasDelord, Jean PierreMaur, MichelaKnox, JenniferCattan, StephaneLee, Kyung HunDel Conte, GianlucaSpringfeld, ChristophLeo, ElisaXyrafas, AlexandrosFairchild, LaurenMardjuadi, FebyChan, Stephen L
27-Jan-2024
 
Phase I/II study of the LAG-3 inhibitor ieramilimab (LAG525) ± anti-PD-1 spartalizumab (PDR001) in patients with advanced malignancies
Journal:Journal for ImmunoTherapy of Cancer
Schöffski, PatrickTan, Daniel S.W.Martín, MiguelOchoa-De-Olza, MariáSarantopoulos, JohnCarvajal, Richard D.Kyi, ChrisannEsaki, TaitoPrawira, AmyAkerley, WallaceDe Braud, FilippoHui, RinaZhang, TianSoo, Ross A.Maur, MichelaWeickhardt, AndrewKrauss, JürgenDeschler-Baier, BarbaraLau, AllenSamant, Tanay S.Longmire, TylerChowdhury, Niladri RoySabatos-Peyton, Catherine A.Patel, NidhiRamesh, RadhaHu, TiancenCarion, AnaGusenleitner, DanielYerramilli-Rao, PadmajaAskoxylakis, VasileiosKwak, Eunice L.Hong, David S.
2022
Showing results 1 to 3 of 3